Slide Process Products Services Contact Us

From policy to practice

MISSED IT?

From Policy to Practice

How Prescription Drug Affordability
Boards May Impact Patients

Lisa Kennedy Co-Founder and Chief
Economist, Innopiphany

Jason Harris VP of Government Relations
and Advocacy National Psoriasis

Carl Schmi Executive Director,
HIV + Hepatitis Policy Institute

WEBINAR RECORDING HERE arrow_forward Explore Solutions → Webinar Prescription Discover More Hear from our guest speakers to learn how advocating for better access, coverage, and reimbursement of Prescription Digital Therapeutics can be a game changer for mental health equity - and what you can do to spur change AFP White Paper Discover More Alternative Funding Programs
What Employers need to know

Prepared by Innopiphany LLC. and supported by Boehringer Inghelheim Pharmaceuticals, Inc. Patient Centric Discover More ENSURING EQUITABLE ACCESS FOR ALL PATIENTS
Leverage our expertise to identify and implement targeted solutions to prioritize patient-centered care and address the unique needs of underserved populations. Unparalleled Quality Discover More TRUST IN OUR DEPTH OF EXPERIENCE
Our team of expert consultants understand the challenges and complexities facing the healthcare industry today, and we are committed to providing customized solutions to meet the unique needs of each of our clients. Rapid Delivery Discover More RAPID ON TIME DELIVERY
At Innopiphany our world revolves around you. Through our intensive project management system and agile approach and execution, we ensure on-time delivery so you can make the key decisions to keep your business growing. Guaranteed Results Discover More RESULTS THAT DELIVER TRUE MARKET VALUE
At Innopiphany, it’s our job to make you look good. We go above and beyond as impact whisperers in making sure that you have the right intelligence at the right time to be successful.

 

Slide

HEALTHCARE STRATEGY, MARKET ACCESS, REAL WORLD EVIDENCE, VALUE POLICY

Innopiphany specializes in life science consulting focused on market access, large scale data analytics, modeling, health economics outcomes research, forecasting and evaluating market opportunity. Innopiphany can help you achieve your goals by leveraging our deep understanding of the healthcare industry through cutting-edge research methodologies and innovative solutions. Innopiphany helps you bring your big idea to life.

 
 

Slide 65 ICER engagements supporting manufacturers 1k Economic and outcomes studies published in over 30 countries 25 Years of experience in areas data analytics, market research and HEOR DISCOVER MORE
 
 

Slide

OUR PRODUCTS

At Innopiphany, we are passionate about using cutting-edge technology to deliver solutions that are tailored to the specific challenges of our clients. Our suite of products enables organizations to leverage the latest advances in predictive analytics, utilize custom-built tools and solutions and connect with a wide range of patient advocacy groups.

 
 

Sentinnel AI DISCOVER MORE SENTINNEL AI
Innopiphany has released a revolutionary machine-learning software, Sentinnel, designed to predict the likelihood of a future ICER assessment for pharmaceutical products. Custom Data Solutions DISCOVER MORE CUSTOM DATA SOLUTIONS
At Innopiphany our world revolves around you. Through our intensive project management system and agile approach and execution, we ensure on-time delivery so you can make the key decisions to keep your business growing. Patient Advocacy Database DISCOVER MORE PATIENT ADVOCACY DATABASE
Our Patient Advocacy Database tracks contacts for numerous patient groups across dozens of disease areas, making it an ideal foundation for stakeholder mapping and community outreach.
 
 

Slide

SERVICES

Exceedingly good service, extraordinary strategic insights and unparalleled expertise. Innopiphany specializes in life science consulting focused on market access, large scale data analytics, modeling, forecasting and evaluating market opportunity. We have worked in over 30 countries and have extensive expertise in the U.S., United Kingdom, France, Germany, Spain, Italy, Japan and South Korea. We have a 100% repeat business rate because our clients cannot replicate the service they find in us anywhere else. As our client, we will go above and beyond in making sure that you have the insights you need to be successful. Our services are outlined below:

MARKET ACCESS & STRATEGY
Helping you understand & quantify the Market Opportunity

​Opportunity Assessment
​Market Forecasting & Scenario Analysis
​​Competitive Analysis
Indication Sequencing
​Business Planning
​Financial Analysis
Pricing & Reimbursement & impact on market opportunity
​Investor Presentations VALUE POLICY
Increasing your Influence & Policy Impact

ICER Unsupported Price Increase: national & state level
​Pricing legislation at state & federal
Value policy strategy development
Surveillance & trend analysis
​​Detailed value policy-analysis
Impactful tactical response
​External communications & engagement
​Internal messaging and training HEALTH DATA ANALYTICS AND REAL WORLD EVIDENCE
Decision-making & Strategy Fluent in Data

- Data analysis planning
- Digital health strategy
- Implementation science & RWE
- ​Database cleaning, preparation & dataset blending
- ​Predictive analytics & next generation analytic platforms
- Real-time data incorporation into decision-algorithms for rapid insights
- Strategic recommendations using a multi-disciplinary team
- Outcomes insights that re-direct resources and thinking towards better patient health
- Innovation employing data to inform decision-making with quantified impact HEALTH ECONOMICS & REIMBURSEMENT
Ensuring payers fund your product

Global reimbursement assessments
Advisory panels
​ICER responses & experience going back to 2015
Health Economic study design and implementation
​Peer-reviewed publication and value communications
Value framework global strategy PATIENT ADVOCACY &
HEALTH EQUITY
Engaging patient advocacy organizations on

​- Access
- Policy issues
- HTA commentary
- Health disparity
- Representation
- Manufacturer collaboration ICER SUPPORT
Successfully engaging the Institute for Clinical and Economic Review

ICER Unsupported Price Increase: national & state level
ICER Value Frameworks
ICER Product Assessments
ICER Readiness & Stage-gating tool
Proprietary searchable database of all ICER assessments
ICER Scenario Analysis and best practices tool
Stakeholder engagement OUR SERVICES IN DEPTH If you want to learn more about what we offer DISCOVER MORE

 

Slide "The Glasshouse" If you like wide, open spaces, this house is exactly what you're looking for 250 m² living area 5 Bedrooms 3 Bathrooms 30 m² outdoor pool Starting at $5,000,000 excl. customization Contact Us Slide "The Monolith" If you like wide, open spaces, this house is exactly what you're looking for 390 m² living area 2 Bedrooms 2 Bathrooms 3 Floors Starting at $3,200,000 excl. customization Contact Us Slide "Garden Of Eden" Large, organic shapes that compliment the warm interior lighting 650 m² living area 3 Bedrooms 3 Bathrooms 4 Floors Starting at $9,500,000 excl. customization Contact Us Slide "Grand Opera" Gigantic rooms and high ceilings make this bulding an extraordinary masterpiece 1350 m² living area 6 Bedrooms 5 Bathrooms 1 Floors Starting at $12,500,000 excl. customization Contact Us
 
 

Slide

THE TEAM

At Innopiphany, our team of healthcare consultants is dedicated to helping your organization achieve their goals. Get to know our team and discover how we can help your organization succeed.

 
 

Lisa Kennedy Managing Principal Dr. Lisa Kennedy specializes in strategy, new business model innovation, marketing, market access, macroeconomic health analysis and commercialization. Dr. Kennedy was GM for the Lewin Group Europe and in 2005, Dr. Kennedy joined GE Healthcare as Chief Economist where she received the CEO’s President Award in this role. She has also held roles as Global Head of Marketing Operations for GE Healthcare’s 1500-strong marketing organization, where she managed the innovation portfolio of over 200 products and services; and led GE Healthcare’s strategy (Growth Playbook) during which the company grew $2B. In 2009 she was awarded the GE Vice Chairman’s Award from John Rice. As Chief Marketing Officer for healthymagination, she led innovation including consumer health incubation and strategic marketing including all branding efforts. Under her leadership, Dr. Kennedy and her team have been recognized with awards from the UN, the White House, IDEA, the Triple Negative Foundation and the National Association of Female Executives. She was a curator for TEDMED’s 2013 Start-Up HIVE, a mentor for Rock Health and is Adjunct Faculty for Singularity University. Dr. Kennedy has several peer-reviewed articles, including an editorial for the British Journal of Cardiology. She has spoken over 100 times internationally on healthcare open innovation, crowdsourcing, disruptive growth, affordability, eHealth, health policy, ambient intelligence and quantified self, including for NASA, the NHS, the EU, SXSW, FutureMed and the White House Office of Science and Technology Policy (OSTP), most recently keynoting for HIMSS. The Wall Street Journal and National Public Radio have quoted Dr. Kennedy on future healthcare trends in consumer health. At the age of 25, she received the 1994 Russel Trust Award and the Gray Prize for research supported by Sir John Crofton that changed WHO practice in the treatment of tuberculosis in Addis Ababa, Ethiopia. Junko Saber Managing Principal Junko Saber has over 20 years of life sciences experience, with the past 10 years in life sciences management consulting. She is an expert in Excel modeling, market forecasting, marketing strategy and core messaging. She has expertise in conducting global qualitative research and in moderating advisory boards. Junko’s experience ranges across a variety of therapeutic areas, including, but not limited to endocrinology, cardiology, oncology, and CNS and HCV. Prior to consulting, Junko spent a decade working in industry at Merck, Genzyme and Abbott Laboratories, where she held various positions in project management, clinical development, resource and research planning and regulatory affairs. Junko holds an MBA from New York University and a Bachelor Degrees in Chemistry and Japanese from the University of California at Berkeley. Mahmoud Loghman-Adham Chief Medical Officer Mahmoud Loghman-Adham, MD is a pediatric nephrologist by training, currently a consultant to pharmaceutical and biotech industry. Most recently, he was a Medical Director at Baxalta (now part of Shire), in Westlake Village, California. He provides strategic medical and scientific advice on clinical trial design and execution and on business development, including due diligence for new molecules to treat orphan diseases. Prior to joining Baxalta, he was a Senior Medical Director and a Translational Medicine Leader at Hoffmann-La Roche Inc, starting in 2001. He has led clinical trials from Phase 2 to 4 in anemia, renal diseases, inflammatory and autoimmune diseases, emphysema/COPD, and hematology /oncology. He has worked on biomarker identification and selection and their incorporation into proof-of-concept clinical trials. His areas of interest include chronic kidney disease, nephrotoxicity, inflammatory/auto-immune diseases and pulmonary diseases. Cody Dunn Senior Associate Dr. Cody Dunn, Senior Associate, was Cal State Long Beach’s Department of Electrical Engineering Outstanding Baccalaureate in 2016. In 2021, he graduated with a PhD in Biomedical Engineering from UC Irvine (UCI). During his PhD, he earned the Cardiovascular Applied Research and Entrepreneurship Fellowship and studied optical techniques for monitoring pulsatile blood flow and tissue oxygenation. He also conducted market research for his patent pending technology through the UCI NSF iCorps and Wayfinder Incubator business startup programs. After earning his PhD, Cody joined Rockley Photonics as a Senior Biomedical Optics Engineer working on a cuffless blood pressure (BP) sensor. He was quickly promoted to Staff Biomedical Optics Engineer and functioned as the BP Algorithm Team Lead. Outside of work, Cody enjoys bouldering at the local climbing gym and 7v7 soccer. Susan Haynie Principal Dr. Susan Haynie is a Data Scientist and Applied Demographer specializing in custom geospatial, demographic and data analytics services. She creates unique research approaches by incorporating cross-industry experience and advanced skills in Alteryx (a leading data science, big data and machine learning platform). She has demonstrated success working in multiple industries including healthcare, retail, utilities, and entertainment. She is an expert in business information evaluation and acquisition, data cleansing, formatting of large unstructured datasets to reveal new information, and statistical and mathematical modeling. Highlights of her work include identifying high-priority, at-risk consumers by analyzing sales data for a major medical organization; estimating health care and insurance-potential models for the elderly population based on geo-demographics and survey response patterns; developing models of age-specific fertility / mortality rates for China accounting for variations in the one-child policy and migrant population flows by region; and, following the 2008 Sichuan, China earthquake, calculating affected population counts and locating health facilities by varying levels of earthquake intensity, improving response time and resource mobilization for life-saving relief organizations including the IFRC. Dr. Haynie was awarded a National Institute of Health SBIR (Small Business Innovation Research) grant –- “Small Area Demographic Estimates for China with Remote Sensing, GIS and Spatial Modeling.” She is a published author and has presented at conferences in the USA and China. She received her Ph.D. in Sociology (Demography and Advanced Quantitative Methods) from the University of Southern California, and was awarded the 2018 Alteryx Designer Advanced Certification. Martin Zagari Principal Dr. Martin Zagari – Principal, Innopiphany is the former Vice President of Global Health Economics at Amgen. In this role, he directed the planning, execution and scientific dissemination of worldwide economic and value evidence for Amgen’s entire product portfolio from early stage molecules to marketed products. Prior to Amgen, Dr. Zagari held various positions at Johnson & Johnson in Health Economics, Medical Affairs, and Strategic Marketing. These positions included: Executive Director in J&J Corporate Strategic Marketing for the erythropoietic agents, Medical Director for erythropoietic treatments in oncology at Ortho Biotech, and Director positions in Health Economics. Prior to that, Dr. Zagari worked in Health Economics and Outcomes consulting at Technology Assessment Group/Lewin-TAG, based in San Francisco. Martin received his MD from Stanford University, an MBA from Rutgers University, and BS in Biology from the University of North Carolina at Chapel Hill and is trained in anesthesiology. He is currently also pursuing his Master of Engineering in Artificial Intelligence at University of San Diego. Bradley Stolshek Principal Bradley Stolshek is a seasoned health economics professional with over 3 decades of experience in the discipline. Throughout his career, he has honed a diverse payer, access, policy and health economics skill set, while working in BioPharma on both Development and On-Market products. His proficiency extends to generating and effectively communicating data to Payers and Regulators, employing Patient Outcomes, Models, and Database Analysis. Moreover, he has a remarkable aptitude for crafting Health Technology Assessment, Payer-based and regulatory packages, as well as developing valuable tools. His therapeutic expertise spans various domains, encompassing Inflammation (Rheum, Derm, GI), Bone, Respiratory, Nephrology, Obesity (prior Roche experience) and select aspects of Oncology. He was previously the Director and TA Lead for Health Economics in the Inflammation therapeutic area at Amgen in Thousand Oaks. While at Amgen, he also worked in Washington DC for the Global Government Affairs team and was the lead for the field-based Health Outcomes team. He started his Health Economics career at Hoffmann-LaRoche and his PharmD is from UCSF. Kyra Salviche-Lee Consultant Dr. Kyra Lee graduated from Caltech with a PhD in Chemistry in 2020 with a research background in bio-analytics and diagnostic device work. She specialized in semiconductor physics, 2-D materials, chemical synthesis, and data visualization/statistical techniques. She also held a scientific advising role at Quinn Emanuel Urquhart & Sullivan, LLP advising on various IP cases such as Caltech vs. Broadcom and Apple (error correction coding) which won a $1.1 billion dollar verdict in Jan 2020. She has experience in evaluating novel decision-making in HTA and outcomes, RWE, diagnostics and COVID-19 evidence and HTA. She also volunteered for the Federal Public Defender’s office in Los Angeles to advise as a science consult on various chemicals involved with methamphetamines to better equip the office on current/future drug cases. At the age of 22 she won the undergraduate researcher of the year in the 2012 American Chemical Society (ACS) Division of Analytical Chemistry. Kat Irwin Consultant Katarina Irwin graduated the University of Southern California in 2017 with a Bachelor of Science in Mechanical Engineering and carried on to obtain her Masters of Science in Marketing Analytics at her alma mater. She is experienced in alternative payment models, stakeholder mapping, modeling, and crafting ICER response documents such as Value for Cures and the 2019 Sickle Cell Disease assessment. Katarina has expertise in health care analytics, data visualization, coding, forecasting & valuation, and market research for healthcare, engineering, and business applications for both clinical stage and commercial therapies. She has worked in several therapeutic and policy areas including population health analytics and companion diagnostics as well as therapeutic areas such as oncology, rare, and infectious disease. Prior to Innopiphany, Katarina worked as an analyst at finance/valuation and industrial corporations.

 

Slide

Contact us

We are here to help you navigate the complex landscape of healthcare with our expert consulting services. Contact us today to learn how we can help your organization achieve its goals and improve patient outcomes.

Office Hours Monday - Friday: 09:00 - 17:00 5251 California Ave, Irvine
CA 92617 Contact info@innopiphany.com +1 949 304 5052 Linked In Privacy Policy Imprint © Copyright 2024